1 / 22

UKRR Annual Informatics Meeting, September 2013

Highlights from the 15 th Annual Report . Rishi Pruthi Research Fellow UK Renal Registry. UKRR Annual Informatics Meeting, September 2013. The Fifth Edition of the Clinical Practice Guidelines. http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx. DEMOGRAPHY.

nysa
Télécharger la présentation

UKRR Annual Informatics Meeting, September 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Highlights from the 15th Annual Report Rishi Pruthi Research Fellow UK Renal Registry UKRR Annual Informatics Meeting, September 2013

  2. The Fifth Edition of the Clinical Practice Guidelines http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx

  3. DEMOGRAPHY RRT incidence rates between 1980 and 2011 UK Renal Registry 15th Annual Report

  4. Figure 1.6. Median age of incident RRT patients by centre in 2011 White points indicate transplant centres UK Renal Registry 15th Annual Report

  5. Population aged 65 and over, 2011 England and Wales local and unitary authorities

  6. Figure 1.2. Age/gender standardised incidence ratio (2006–2011) by percentage non-White UK Renal Registry 15th Annual Report

  7. RRT incidence rates in the countries of the UK 1990–2011 UK Renal Registry 15th Annual Report

  8. Figure 1.14. International comparison of RRT incidence rates in 2010 Non UK data from USRDS UK Renal Registry 15th Annual Report

  9. Prevalence rate of RRT patients per million population by age and gender on 31/12/2010

  10. MODALITY Growth in prevalent patients by treatment modality at the end of each year 1997–2011 UK Renal Registry 15th Annual Report

  11. RRT modality at 90 days (incident cohort 1/10/2010 to 30/09/2011) UK Renal Registry 15th Annual Report

  12. Figure 2.6. Treatment modality in prevalent RRT patients on 31/12/2011 UK Renal Registry 15th Annual Report

  13. Figure 2.7. Treatment modality distribution by age in prevalent RRT patients on 31/12/2011 UK Renal Registry 15th Annual Report

  14. ACCESS TO TRANSPANTATION Figure 9.4. Median time to wait listing for a kidney transplant, by renal centre (centres with <10 patients excluded) UK Renal Registry 15th Annual Report

  15. ACCESS TO TRANSPANTATION Patients starting dialysis in a non-transplanting centre was associated with being less likely to be registered for transplantation (adjusted OR 0.8, 0.74-87) After adjustment for age, ethnicity, gender an PRD there were significant centre differences for the probability of being activated on the kidney tx waiting list and the probability of receiving a renal transplant (all sources)

  16. Figure 4.3. Primary renal disease percentage in incident and prevalent paediatric ERF patients in 2011 for whom a causative diagnosis was reported UK Renal Registry 15th Annual Report

  17. Figure 4.4. Treatment modality at start of RRT by 5 year time period UK Renal Registry 15th Annual Report

  18. OPPORTUNITIES & THE FUTURE • CKD stage 5 patients to understand conservative and withdrawal issues to allow adjustment for survival and other outcomes (quality of life) • AKI • RADAR • Improving data returns and New Renal Dataset • Specific need for research focused on improving outcomes in the elderly multi-morbid population

  19. VALID REPRODUCIBLE COMPLETE RELIABLE

More Related